EyePoint (EYPT) Total Debt (QoQ) (2018 - 2023)
EyePoint (EYPT) Total Debt (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -12.87% |
| Dec 31, 2022 | 0.15% |
| Sep 30, 2022 | 0.18% |
| Jun 30, 2022 | 0.18% |
| Mar 31, 2022 | 8.26% |
| Dec 31, 2021 | 0.46% |
| Sep 30, 2021 | 0.44% |
| Jun 30, 2021 | -4.95% |
| Mar 31, 2021 | 0.39% |
| Dec 31, 2020 | -25.21% |
| Sep 30, 2020 | 1.03% |
| Jun 30, 2020 | 5.33% |
| Mar 31, 2020 | 1.04% |
| Dec 31, 2019 | 1.05% |
| Sep 30, 2019 | 1.04% |
| Jun 30, 2019 | 44.75% |
| Mar 31, 2019 | 81.33% |
| Dec 31, 2018 | 0.90% |
| Sep 30, 2018 | 0.89% |
| Jun 30, 2018 | 34.70% |